Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c

Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• XP Inc eyes US banking license as next business step